Operating Expenses

R&D

MKS Instruments R&D increased by 5.2% to $81.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 15.7%, from $70.00M to $81.00M. Over 3 years (FY 2021 to FY 2025), R&D shows an upward trend with a 14.3% CAGR.

Analysis

StatementIncome Statement
SectionOperating Expenses
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ1 2014
Last reportedQ1 2026

How to read this metric

Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.

Detailed definition

Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...

Peer comparison

Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.

Metric ID: research_and_development

Historical Data

17 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$50.00M$52.00M$51.00M$52.00M$53.00M$63.00M$73.00M$72.00M$70.00M$66.00M$70.00M$65.00M$70.00M$76.00M$76.00M$77.00M$81.00M
QoQ Change+4.0%-1.9%+2.0%+1.9%+18.9%+15.9%-1.4%-2.8%-5.7%+6.1%-7.1%+7.7%+8.6%+0.0%+1.3%+5.2%
YoY Change+6.0%+21.2%+43.1%+38.5%-2.8%+0.0%+15.2%+8.6%+18.5%+15.7%
Range$50.00M$81.00M
CAGR+12.8%
Avg YoY Growth+16.4%
Median YoY Growth+15.4%
Current Streak5 quarters growth

Frequently Asked Questions

What is MKS Instruments's r&d?
MKS Instruments (MKSI) reported r&d of $81.00M in Q1 2026.
How has MKS Instruments's r&d changed year-over-year?
MKS Instruments's r&d increased by 15.7% year-over-year, from $70.00M to $81.00M.
What is the long-term trend for MKS Instruments's r&d?
Over 3 years (2021 to 2025), MKS Instruments's r&d has grown at a 14.3% compound annual growth rate (CAGR), from $200.00M to $299.00M.
What does r&d mean?
The money spent on creating new products or improving existing ones to drive future growth.